மருந்து உத்திகள் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து உத்திகள் குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து உத்திகள் குழு Today - Breaking & Trending Today

EPIC Acquires Pharmaceutical Strategies Group | Massachusetts Newswire


SAN FRANCISCO, Calif., Feb 04, 2021 (SEND2PRESS NEWSWIRE) EPIC Holdings, Inc. (EPIC) announced today that it has agreed to acquire Pharmaceutical Strategies Group (PSG). The move incorporates the expertise and resources of the nation’s largest independent pharmacy benefit consulting firm into EPIC’s Employee Benefits Consulting practice.
As a strategic partner to self-insured employers, health plans and health systems, PSG is an experienced navigator of the complex drug pricing market, and generates more than $4.8 billion in drug cost savings for clients each year.
“The opportunity to continue the next phase of our journey with EPIC is exciting,” said Dave Borden, PSG Founder. “For more than 25 years, our dedicated clinicians and consultants have relentlessly advocated for clients, harnessing innovation to deliver the highest standard of pharmacy benefits consulting and technology.” ....

United States , Michael Lonergan , Steve Denton , Dave Borden , Scott Schanen , Holdings Inc , National Employer Consulting , Strategies Group , Pharmaceutical Strategies Group , Benefits Consulting , Employer Consulting , Employee Benefits , Specialty Programs , Private Client , ஒன்றுபட்டது மாநிலங்களில் , மைக்கேல் லொனேர்காண் , ஸ்டீவ் டென்டன் , டேவ் பார்த்தேன் , ஹோல்டிங்ஸ் இன்க் , தேசிய முதலாளி ஆலோசனை , உத்திகள் குழு , மருந்து உத்திகள் குழு , நன்மைகள் ஆலோசனை , முதலாளி ஆலோசனை , ஊழியர் நன்மைகள் , சிறப்பு ப்ரோக்ர்யாம்ஸ் ,

EPIC Insurance Brokers & Consultants Acquires Pharmaceutical Strategies Group


SAN FRANCISCO, Calif., Feb 04, 2021 (SEND2PRESS NEWSWIRE) EPIC Holdings, Inc. (EPIC) announced today that it has agreed to acquire Pharmaceutical Strategies Group (PSG). The move incorporates the expertise and resources of the nation’s largest independent pharmacy benefit consulting firm into EPIC’s Employee Benefits Consulting practice.
As a strategic partner to self-insured employers, health plans and health systems, PSG is an experienced navigator of the complex drug pricing market, and generates more than $4.8 billion in drug cost savings for clients each year.
“The opportunity to continue the next phase of our journey with EPIC is exciting,” said Dave Borden, PSG Founder. “For more than 25 years, our dedicated clinicians and consultants have relentlessly advocated for clients, harnessing innovation to deliver the highest standard of pharmacy benefits consulting and technology.” ....

United States , Michael Lonergan , Steve Denton , Dave Borden , Scott Schanen , Holdings Inc , National Employer Consulting , Strategies Group , Pharmaceutical Strategies Group , Benefits Consulting , Employer Consulting , Employee Benefits , Specialty Programs , Private Client , ஒன்றுபட்டது மாநிலங்களில் , மைக்கேல் லொனேர்காண் , ஸ்டீவ் டென்டன் , டேவ் பார்த்தேன் , ஹோல்டிங்ஸ் இன்க் , தேசிய முதலாளி ஆலோசனை , உத்திகள் குழு , மருந்து உத்திகள் குழு , நன்மைகள் ஆலோசனை , முதலாளி ஆலோசனை , ஊழியர் நன்மைகள் , சிறப்பு ப்ரோக்ர்யாம்ஸ் ,